Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,764 | -49,906 | -28,599 | -19,394 | -8,805 |
| Depreciation Amortization | N/A | 102 | 102 | 87 | 43 |
| Income taxes - deferred | N/A | -1,803 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -267 | 858 | 205 | 598 | 134 |
| Other Working Capital | 1,125 | 259 | 119 | 2,357 | 732 |
| Other Operating Activity | 3,098 | 25,889 | 8,405 | 5,210 | 2,679 |
| Operating Cash Flow | $-5,808 | $-24,602 | $-19,769 | $-11,142 | $-5,217 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 60,000 | 60,000 | 60,000 | 60,000 |
| Financing Cash Flow | $N/A | $60,000 | $60,000 | $60,000 | $60,000 |
| Beginning Cash Position | 60,855 | 25,457 | 25,457 | 25,457 | 25,457 |
| End Cash Position | 55,047 | 60,855 | 65,688 | 74,315 | 80,240 |
| Net Cash Flow | $-5,808 | $35,398 | $40,231 | $48,858 | $54,783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,808 | -24,602 | -19,769 | -11,142 | -5,217 |
| Free Cash Flow | -5,808 | -24,602 | -19,769 | -11,142 | -5,217 |